Axonics, Inc. (AXNX) Financials
AXNX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 719.9 million | 82.4 million |
2023-09-30 | 660.7 million | 50.1 million |
2023-06-30 | 649.0 million | 33.3 million |
2023-03-31 | 665.7 million | 89.1 million |
AXNX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 4.3 million | 11.1 million |
2023-09-30 | 11.2 million | 11.5 million |
2023-06-30 | -19.5 million | 11.2 million |
2023-03-31 | -1.6 million | 10.7 million |
AXNX Net Income
No data available :(
AXNX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 345.0 million | - | 27.6 million |
2023-09-30 | 344.7 million | - | 2.8 million |
2023-06-30 | 331.5 million | - | 3.0 million |
2023-03-31 | 357.1 million | - | 8.7 million |
AXNX Shares Outstanding
AXNX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1.3 million | 9.7 million | 11.1 million | 55.1 million |
2023-09-30 | 1.2 million | 8.2 million | 11.8 million | 47.5 million |
2023-06-30 | 256000 | 8.9 million | 10.7 million | 44.3 million |
2023-03-31 | 794000 | 8.1 million | 12.2 million | 42.7 million |
AXNX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 109.7 million | 29.2 million |
2023-09-30 | 93.1 million | 24.0 million |
2023-06-30 | 22.7 million | 22.7 million |
2023-03-31 | 70.7 million | 18.2 million |
AXNX
Price: $66.69
52 week price:
Earnings Per Share: -0.12 USD
P/E Ratio: -295.22
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 679900
Market Capitalization: 3.4 billion